Literature DB >> 11697080

Quantitation in receptor pharmacology.

T P Kenakin1.   

Abstract

The activity of drugs on receptors can be visualized in appropriate systems. However, for comparisons of activity to be made, these effects must be quantified. The common currency for this quantitation is the dose-response curve. Thus, the shape, location (along the concentration axis), and maximal asymptote of dose-response curves are used to quantify drug activity and comparisons to mathematical models of receptors are made to describe mechanism of action. This review cites examples of where these quantitative procedure yield information beyond what is readily apparent through observation of the data and thus support the use of quantitative methods to maximize the information gained from experiments.

Mesh:

Substances:

Year:  2001        PMID: 11697080

Source DB:  PubMed          Journal:  Receptors Channels        ISSN: 1060-6823


  5 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.

Authors:  R G Pertwee; A C Howlett; M E Abood; S P H Alexander; V Di Marzo; M R Elphick; P J Greasley; H S Hansen; G Kunos; K Mackie; R Mechoulam; R A Ross
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  Procedure for calculation of potency and efficacy for ligands acting on Gs- and Gi-coupled receptors.

Authors:  Eddi Meier; Arne Schousboe; Bo Belhage
Journal:  Neurochem Res       Date:  2012-09-26       Impact factor: 3.996

3.  Glucagon and a glucagon-GLP-1 dual-agonist increases cardiac performance with different metabolic effects in insulin-resistant hearts.

Authors:  L N Axelsen; W Keung; H D Pedersen; E Meier; D Riber; A L Kjølbye; J S Petersen; S D Proctor; N-H Holstein-Rathlou; G D Lopaschuk
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 4.  A pharmacological primer of biased agonism.

Authors:  Bradley T Andresen
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2011-06       Impact factor: 2.895

Review 5.  Intercellular Lipid Mediators and GPCR Drug Discovery.

Authors:  Dong-Soon Im
Journal:  Biomol Ther (Seoul)       Date:  2013-11       Impact factor: 4.634

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.